Results 141 to 150 of about 237,385 (264)

Immune Checkpoint Inhibitor–Related Myositis and Associated Triad Overlap Syndrome

Arthritis Care &Research, EarlyView.
Objective Immune checkpoint inhibitor (ICI) myositis is a rare but a highly morbid condition, particularly with the ICI myositis triad syndrome of myositis, myocarditis, and myasthenia gravis. We report the clinical characteristics of ICI myositis and all‐cause mortality in these patients.
Selene Rubino, Grant W. Cannon, Brian C. Sauer, Jorge Rojas, Gregory J. Stoddard, Gary A. Kunkel, Jessica A. Walsh, Bryant R. England, Joshua F. Baker, Tawnie J. Braaten   +9 more
wiley   +1 more source

The HIV/HBV Co‑infection Paradox: Immune Modulation Amid Persistent Risk [Response To Letter]. [PDF]

Infect Drug Resist
Bobadilla R, MacLean F, Dave S, Blackard JT, Gianella S.   +4 more
europepmc   +1 more source

Does Long‐Term Lower Extremity Strength Training in Adults With Knee Osteoarthritis and Varus Alignment Reduce Knee Joint Loading During Gait?

Arthritis Care &Research, EarlyView.
Objective We examined whether 18 months of strength training in individuals with knee varus alignment and medial tibiofemoral osteoarthritis (OA) reduced knee joint loads during walking compared to an attention control group. Methods This study was a secondary analysis of a randomized clinical trial that compared the effects of strength training to a ...
Stephen P. Messier, Matthew N. Vigliotti, Paige E. Rice, Brian Pietrosimone, Shannon L. Mihalko, Edward H. Ip, Richard F. Loeser, David J. Hunter, Ali Guermazi, Ryan Hill, Santiago Saldana, Kim L. Bennell, Paul DeVita   +12 more
wiley   +1 more source

Paradoxical inflammatory switches during biologic therapy: a mechanistic framework, clinical algorithm, and pediatric illustrations. [PDF]

Front Pediatr
Kowacka M, Dec M, Arasiewicz H.
europepmc   +1 more source

Rheumatologic Manifestations of Patients With Type B Insulin Resistance

Arthritis Care &Research, EarlyView.
Objective The objectives of this study were to identify laboratory and clinical features associated with type B insulin resistance (TBIR), a rare condition caused by autoantibodies that inhibit the insulin receptor, most frequently occurring in the setting of systemic lupus erythematosus (SLE), and to increase awareness of this rare, life‐threatening ...
S. Amara Ogbonnaya, Sandra G. Williams, Raphael A. Kirou, Marissa Lightbourne, Rebecca J. Brown   +4 more
wiley   +1 more source

Looking to Philadelphia for Trends in Lung Cancer Risk and Screening Adherence Among Asian American Patients

CHEST Pulmonary
Travis L. Dotson, MD, Christina R. Bellinger, MD   +1 more
doaj   +1 more source

A Single Dose Study of Pembrolizumab in People With HIV Infection Who are Immunologic Nonresponders. [PDF]

Open Forum Infect Dis
Kuruppu J, Purdy JB, Pauls C, Rogan DC, Blazkova J, Kardava L, Sewack AB, Proschan MA, Migueles SA, Connors M, Webber JD, Meeks T, Przygonska PA, Adelsberger JW, Higgins J, Rupert A, Moir SL, Chun TW, Lane HC, Kovacs JA.   +19 more
europepmc   +1 more source

Prevalence of Systemic Lupus Erythematosus in Australia, 2010–2022: A Population‐Based Study Using Linked National Administrative Health Data

Arthritis Care &Research, EarlyView.
Objective Systemic lupus erythematosus (SLE) is a heterogenous inflammatory condition with widely varying global prevalence estimates. The frequency of SLE in the general population of Australia has been reported to be notably lower than contemporary estimates in countries such as the United States or United Kingdom, at 19 to 39 per 100,000 as opposed ...
Lucinda Roper, Rachel Black, Joanna Tieu, Winnie Chen, Matthew Parker, Catherine Hill, Natasha Nassar, Mandana Nikpour   +7 more
wiley   +1 more source

miRNA profiles in early systemic sclerosis, organ complications, and treatment response

Chinese Medical Journal
Jing Huang, Sijia Liu, Kun Wang, Yisha Li, Hui Luo, Xiaoxia Zuo, Honglin Zhu, Xiangxiang Pan   +7 more
doaj   +1 more source

Red-yellow Papules and Nodules All over the Body: A Quiz. [PDF]

Acta Derm Venereol
Liu JW, Feng JD, He CX.
europepmc   +1 more source